Ben Franklin Technology Partners of Southeastern Pennsylvania

Ben Franklin Technology Partners of Southeastern Pennsylvania, established in 1982, is a non-profit organization that fosters technological innovation and growth in the region. It primarily invests in early-stage technology companies, having supported over 1,750 such ventures since its inception. The organization also facilitates university-industry partnerships to accelerate scientific discoveries to market, and initiates regional programs to bolster the entrepreneurial ecosystem. Its mission is to create jobs and transform lives by leading the region's technology community to new heights.

Jonathan Beschen

Investment Director, Information Technology Investment Group

Anthony George

Venture Capital Associate, Tech Investment Group

Adare McMillan

CFO

Omar Mencin

Managing Director, Information Technology Investment Group

Scott Nissenbaum

President, CEO and Board Member

Aston Pierce

Director - GO PA Fund and GO PHL Fund

Kathie Jordan Ph.D

Managing Director, Healthcare Investment Group

Past deals in Health Diagnostics

Avisi Technologies

Seed Round in 2022
Avisi Technologies Inc. is a Philadelphia-based company founded in 2017 that specializes in developing innovative solutions for glaucoma treatment. Its primary product, VisiPlate, is a next-generation, nanotechnology-enabled aqueous shunt designed to prevent blindness caused by glaucoma. Through its advanced technology, Avisi Technologies aims to enhance the effectiveness of glaucoma management and improve patient outcomes.

RecoveryLink

Pre Seed Round in 2021
RecoveryLink is a developer of a comprehensive digital recovery support platform aimed at enhancing behavioral health outcomes. The company offers a range of services including electronic recovery records, asynchronous digital training, one-on-one telerecovery peer services, and live video group-based recovery supports. By providing these tools, RecoveryLink enables clients to access effective recovery support solutions that promote organizational efficiency and improve the overall recovery process for individuals seeking assistance. The platform's design focuses on facilitating better engagement and outcomes in the behavioral health sector through innovative technology and supportive resources.

Avisi Technologies

Seed Round in 2021
Avisi Technologies Inc. is a Philadelphia-based company founded in 2017 that specializes in developing innovative solutions for glaucoma treatment. Its primary product, VisiPlate, is a next-generation, nanotechnology-enabled aqueous shunt designed to prevent blindness caused by glaucoma. Through its advanced technology, Avisi Technologies aims to enhance the effectiveness of glaucoma management and improve patient outcomes.

Bainbridge Health

Debt Financing in 2020
Bainbridge Health, Inc. is a Philadelphia-based company founded in 2016 that specializes in developing a clinical intelligence and data analytics platform aimed at enhancing medication safety in hospital settings. The company's offerings include a vendor-agnostic medication safety platform that streamlines data management, reducing the reliance on manual data clerking and ad-hoc reporting. Their solutions, designed for medication safety leaders and hospital safety professionals, include an infusion pump management software known as InfusionWare, which centralizes infusion data to improve patient safety and effectively manage pump information. By mitigating medication errors, Bainbridge Health's platform helps healthcare providers reduce avoidable costs and improve overall patient care.

Repisodic

Debt Financing in 2020
Repisodic, Inc. is a health technology company based in Philadelphia, Pennsylvania, that focuses on streamlining the transition of care for patients moving from hospital settings to post-acute care facilities such as nursing homes and rehabilitation centers. Founded in 2017, the company develops a digital healthcare ecosystem that aids hospitals in managing the discharge process effectively. Its platform utilizes proprietary data and automation to match patients with suitable post-hospital care options, taking into account factors like insurance coverage, clinical capabilities, and provider availability. Repisodic's solutions include the repisodic Choice, which creates dynamic preferred provider networks tailored to patients' needs, and repisodic Link, designed to facilitate referrals and connect post-acute care providers with patients during their care decision-making process. By enhancing the discharge experience, Repisodic aims to improve outcomes for patients, families, and healthcare providers alike.

Cassian Solutions

Seed Round in 2020
Cassian Solutions, Inc. is a company based in Phoenixville, Pennsylvania, that specializes in developing innovative medication management solutions. Founded in 2018, it designs and manufactures a unique phone case medication dispenser alongside a comprehensive application that enhances patient adherence to prescribed treatments. The app features tools for outcome collection, biometric verification, medication reminders, adherence verification, environmental sensing, treatment analysis, real-time communication, and medication distribution. Cassian Solutions serves a diverse clientele, including pharmacies, clinical trial companies, drug manufacturers, and insurers. By addressing critical gaps in patient monitoring and data reporting, the company aims to improve health outcomes and streamline the pharmaceutical value chain, ultimately enhancing the medication experience for patients and healthcare providers alike.

DRSLINQ

Grant in 2020
DRSLINQ is developing a mobile EKG device that is coupled to an interactive application powered by a natural language processing integrated with a machine learning platform to appropriately triage chest pain patients to the ER.

Hava Health

Pre Seed Round in 2019
Hava Health, Inc. is a biotechnology company based in the United States that specializes in developing innovative solutions for nicotine addiction. The company manufactures a smoking cessation device, which includes a connected vape pen that integrates with a smartphone application called Hale. This digital drug therapy device aims to support individuals in their efforts to quit smoking by providing a modern approach to nicotine de-addiction. Through its technology, Hava Health seeks to enhance the effectiveness of smoking cessation efforts and improve health outcomes for users.

Avisi Technologies

Seed Round in 2019
Avisi Technologies Inc. is a Philadelphia-based company founded in 2017 that specializes in developing innovative solutions for glaucoma treatment. Its primary product, VisiPlate, is a next-generation, nanotechnology-enabled aqueous shunt designed to prevent blindness caused by glaucoma. Through its advanced technology, Avisi Technologies aims to enhance the effectiveness of glaucoma management and improve patient outcomes.

Keriton

Seed Round in 2017
Keriton LLC is a company that specializes in providing a pumped breast milk management system tailored for neonatal intensive care units (NICUs). Its platform facilitates the tracking of milk-bottle inventory, feeding orders, and recipes through mobile devices. The system enhances patient safety by implementing first-in-first-out (FIFO) bottle flow management, notifying users of expiry dates, and issuing alerts for potential misfeeds. Additionally, Keriton offers a media-sharing platform that allows nurses to share photos and videos of NICU babies with their mothers, fostering communication and engagement. The company also provides real-time insights into the milk production patterns of lactating mothers. Incorporated in 2016 and based in Philadelphia, Pennsylvania, Keriton's software-as-a-service (SaaS) solution has been deployed in various large healthcare systems, managing over 1.5 million feeds and significantly reducing nursing errors while improving overall patient outcomes.

Shock Analytics

Seed Round in 2016
Shock Analytics LLC is an early-stage biomedical device company based in Philadelphia, Pennsylvania, established in 2016. The firm specializes in the design and manufacture of noninvasive diagnostic devices aimed at improving the management of acute and chronic illnesses. Its primary focus is on developing technology that estimates Systemic Vascular Resistance (SVR), a critical indicator for conditions such as congestive heart failure and sepsis. By utilizing hemodynamic information, Shock Analytics' devices enable healthcare professionals to effectively treat and monitor patients suffering from these serious medical conditions.

Instadiagnostics

Seed Round in 2016
Instadiagnostics Inc. is a company based in Philadelphia, Pennsylvania, that focuses on developing a point-of-care (POC) diagnostic platform. Founded in 2015, the platform aims to bring centralized laboratory testing directly to patients at their bedside, facilitating early diagnosis and treatment monitoring. This innovative approach allows patients to receive timely medical care in various settings, including primary care centers, community clinics, and emergency departments, without the need for additional trips to have blood drawn or enduring long wait times for results. By streamlining the diagnostic process, Instadiagnostics seeks to enhance patient care and satisfaction, reduce the frequency of medical visits, and ultimately lower overall healthcare costs.

GSI Health

Seed Round in 2016
GSI Health, LLC is a health information technology company that specializes in developing a population health management platform. Founded in 2003 and based in Philadelphia, Pennsylvania, with an additional office in New York, GSI Health offers cloud-based software solutions aimed at enhancing care coordination, improving transitions in care, and reducing avoidable hospital readmissions. The platform supports hospitals, health systems, managed care organizations, health plans, Medicaid programs, and community-based organizations by facilitating better communication and information sharing among all healthcare providers involved in a patient's care. It features built-in health information exchange capabilities that allow for effective analytics and reporting, ultimately providing a personalized healthcare experience for patients. As of late 2019, GSI Health operates as a subsidiary of Medecision, Inc.

Ultraflex Systems

Seed Round in 2016
Ultraflex Systems specializes in designing and engineering custom Range of Motion (ROM) braces that enhance movement and promote active living. With over 25 years of experience, the company collaborates closely with physicians, physical therapists, and specialists to deliver innovative orthopedic and neurological solutions. Ultraflex Systems distinguishes itself through a dedicated direct care team, which includes sales professionals and certified orthotists or fitters. This team oversees the entire process from the physician's referral to brace delivery and subsequent patient follow-up. The company’s custom-molded braces are crafted in its fabrication facilities to ensure optimal fit and effectiveness, ultimately improving joint and limb motion and supporting the musculoskeletal system for better patient outcomes.

Essential Medical

Seed Round in 2016
Essential Medical is a family owned & operated business that was started in 1985. We are a broad based supplier of home medical and health related products designed with the needs of the user in mind. Within this online website you will find many different product options to meet a variety of life styles and physical conditions. If you are a home medical equipment dealer and would like to be set up to order Essential products, please click on the Prospective Dealers tab. If you would like to purchase products for yourself, family member or friend, our fine products are available through your local medical equipment dealer or pharmacy. Please consult the yellow pages of your local telephone book under Hospital and Medical Equipment.

Instadiagnostics

Seed Round in 2016
Instadiagnostics Inc. is a company based in Philadelphia, Pennsylvania, that focuses on developing a point-of-care (POC) diagnostic platform. Founded in 2015, the platform aims to bring centralized laboratory testing directly to patients at their bedside, facilitating early diagnosis and treatment monitoring. This innovative approach allows patients to receive timely medical care in various settings, including primary care centers, community clinics, and emergency departments, without the need for additional trips to have blood drawn or enduring long wait times for results. By streamlining the diagnostic process, Instadiagnostics seeks to enhance patient care and satisfaction, reduce the frequency of medical visits, and ultimately lower overall healthcare costs.

Allevi

Seed Round in 2015
Allevi is a pioneering company that develops innovative tools for designing and engineering 3D tissues. It specializes in desktop 3D bioprinters capable of creating functional, three-dimensional living tissues, alongside proprietary bioinks composed of collagen and hyaluronic acid. Allevi's cloud-based platform, Bioprint Online, allows users to design structures, select materials, and monitor the printing process. Its products cater to a diverse clientele, including researchers in tissue engineering, regenerative medicine, material science, and cell biology, as well as industrial and pharmaceutical companies involved in drug testing and development. Additionally, Allevi sells its bioinks online. Founded in 2014 and headquartered in Philadelphia, Pennsylvania, the company was previously known as BioBots, Inc.

DecNut

Seed Round in 2015
DecNut develops point-of-care technologies aimed at enhancing clinical decision-making across various healthcare settings. The company offers tools that integrate evidence-based clinical practice guidelines into the workflows of healthcare providers. By doing so, DecNut enables professionals to optimize resource utilization and improve patient care outcomes. Their solutions facilitate the aggregation, updating, dissemination, and evaluation of tailored clinical decision support, ultimately enhancing the overall quality of clinical judgment in diverse healthcare environments.

Grand Round Table

Seed Round in 2015
Grand Round Table Inc. is a company based in Philadelphia, Pennsylvania, that specializes in developing clinical decision support tools for healthcare providers. Its flagship product, Grand Round Table, is an integrated system designed to enhance the diagnostic capabilities of doctors by leveraging a vast database of deidentified health records, case reports, and evidence-based medical literature. This technology extracts pertinent information from patients' charts and matches it with similar cases, allowing physicians to reference previous treatments and outcomes in comparable scenarios. By facilitating faster and more accurate treatment plans, Grand Round Table aims to improve patient care, reduce unnecessary medical tests and consultations, and ultimately contribute to cost savings for hospitals and clinics. Established in 2011, the company focuses on translating available medical knowledge into actionable insights to support healthcare professionals in making informed decisions for diagnostically challenging cases.

Prescription Advisory Systems & Technology

Debt Financing in 2015
Prescription Advisory Systems & Technology, Inc. is a company based in Jenkintown, Pennsylvania, that specializes in developing software solutions to enhance the management of chronic pain treatment and mitigate the risks associated with prescription drug abuse. Its flagship product, PASTRx, is a Software as a Service (SaaS) platform designed to assist healthcare providers in identifying patients who are suitable for controlled substance prescriptions while highlighting those who may need more complex care or additional safety measures. PASTRx integrates data from multiple sources, allowing for comprehensive patient risk assessments and facilitating the retrieval of prescription monitoring program reports. This user-friendly software promotes auditability and institutional oversight, ultimately contributing to safer prescribing practices and protecting patients, physicians, and healthcare institutions amidst increasing scrutiny regarding prescription medication use. Incorporated in 2013, the company has developed its software with the guidance of pain management practitioners and in collaboration with various states and research initiatives.

Essential Medical

Seed Round in 2014
Essential Medical, Inc. is a medical device company based in Malvern, Pennsylvania, that specializes in the development and marketing of femoral artery vascular closure devices. Founded in 2010, the company focuses on sealing femoral punctures that occur after diagnostic and interventional cardiac catheterization procedures. Essential Medical has developed two key devices, including MANTA, which is designed to close large bore punctures ranging from 10 to 24 French following various vascular access procedures such as transcatheter aortic valve replacement, abdominal aortic aneurysm repair, and balloon aortic valvuloplasty. These closures are critical in the rapidly growing field of interventional cardiology, enabling physicians to address the need for efficient and complication-free closure solutions. As of October 2018, Essential Medical operates as a subsidiary of Teleflex Incorporated.

Allevi

Seed Round in 2014
Allevi is a pioneering company that develops innovative tools for designing and engineering 3D tissues. It specializes in desktop 3D bioprinters capable of creating functional, three-dimensional living tissues, alongside proprietary bioinks composed of collagen and hyaluronic acid. Allevi's cloud-based platform, Bioprint Online, allows users to design structures, select materials, and monitor the printing process. Its products cater to a diverse clientele, including researchers in tissue engineering, regenerative medicine, material science, and cell biology, as well as industrial and pharmaceutical companies involved in drug testing and development. Additionally, Allevi sells its bioinks online. Founded in 2014 and headquartered in Philadelphia, Pennsylvania, the company was previously known as BioBots, Inc.

Brad’s Raw Foods

Seed Round in 2014
Brad’s Raw Foods offers a range of raw veggie chips, leafy kale, and other healthy food products. These snacks are available in flavors such as cheddar, hot kale, red bell pepper, Indian, sun dried tomato, vegan cheese, natural nacho, garlic, jalapeno, and more. Brad’s Raw Foods won the award for the Most Innovative New Product at the Natural Products Expo East in 2011. The company operates an online store and offers its products via many other retail outlets as well. Brad’s Raw Foods was founded in 2009 in the United States.

Vy Corporation

Seed Round in 2014
Vy Corporation is a software development company based in Wayne, Pennsylvania, specializing in shape detection and object analysis for the medical imaging market. The company offers a cloud-based image analysis and data collection service known as CytoSavvy.com, which utilizes its patented CellQuant™ search technology to identify clusters of cells in various types of biopsies. This service aids pathologists and medical researchers by enhancing their ability to analyze complex cell structures efficiently and reliably. Additionally, Vy Corporation provides VectorSavvy.com, a platform that allows users to access image analysis technology, upload images, and view results. The company also engages in the development of custom projects tailored to specific client needs within the medical imaging sector.

HealthQx

Series A in 2014
HealthQx, established in 2012 and headquartered in King of Prussia, Pennsylvania, specializes in Value-based Payment (VBP) analytic software solutions for health plans and providers. Its flagship product, ClarityQx, empowers users to design, implement, and monitor the performance of alternative payment models such as episodic or bundled arrangements. The platform facilitates provider engagement and contract negotiation processes, aiming to enhance consumer care while reducing medical costs.

BioDetego

Seed Round in 2014
BioDetego is focused on advancing cancer diagnostics through its innovative platform, VASPfore, which develops a biomarker test aimed at optimizing cancer treatment protocols. This test assesses the metastatic risk in colorectal cancer patients, allowing for more informed decisions regarding chemotherapy. By accurately identifying high-risk patients who would benefit from treatment, BioDetego seeks to mitigate the unnecessary costs and adverse effects associated with treating low-risk patients. The company anticipates significant savings for payors, estimated at over $150 million annually, through reduced overall treatment expenses. BioDetego is led by David Zuzga, Ph.D., a research scientist with a background in cell and molecular biology, and Giovanni M. Pitari, M.D., Ph.D., a physician and research scientist specializing in Translational Oncology.

Grand Round Table

Seed Round in 2014
Grand Round Table Inc. is a company based in Philadelphia, Pennsylvania, that specializes in developing clinical decision support tools for healthcare providers. Its flagship product, Grand Round Table, is an integrated system designed to enhance the diagnostic capabilities of doctors by leveraging a vast database of deidentified health records, case reports, and evidence-based medical literature. This technology extracts pertinent information from patients' charts and matches it with similar cases, allowing physicians to reference previous treatments and outcomes in comparable scenarios. By facilitating faster and more accurate treatment plans, Grand Round Table aims to improve patient care, reduce unnecessary medical tests and consultations, and ultimately contribute to cost savings for hospitals and clinics. Established in 2011, the company focuses on translating available medical knowledge into actionable insights to support healthcare professionals in making informed decisions for diagnostically challenging cases.

Essential Medical

Seed Round in 2014
Essential Medical is a family owned & operated business that was started in 1985. We are a broad based supplier of home medical and health related products designed with the needs of the user in mind. Within this online website you will find many different product options to meet a variety of life styles and physical conditions. If you are a home medical equipment dealer and would like to be set up to order Essential products, please click on the Prospective Dealers tab. If you would like to purchase products for yourself, family member or friend, our fine products are available through your local medical equipment dealer or pharmacy. Please consult the yellow pages of your local telephone book under Hospital and Medical Equipment.

Fitly

Seed Round in 2014
Fitly, Inc. specializes in developing innovative solutions that promote healthy eating among families and children. The company offers the SmartPlate App, which employs food recognition technology to assist users in planning, purchasing, and preparing nutritious meals. This app allows individuals to choose from various goal-specific programs or create custom plans, while pairing with a countertop device that accurately analyzes and tracks the nutritional content of meals. Fitly's SmartPlate TopView device provides personalized guidance on healthy eating habits by analyzing entire meals and offering insights into macro and micronutrient intake. The company's solutions focus on various aspects of wellness, including weight management, portion control, and dietary needs, aiming to enhance human health without the need for restrictive diets. Established in 2011, Fitly is headquartered in Philadelphia, Pennsylvania.

EyeIC

Venture Round in 2012
EyeIC, Inc. is a medical technology company based in Wayne, Pennsylvania, specializing in the development and commercialization of imaging technologies for healthcare applications. Founded in 2004, EyeIC focuses on providing innovative solutions for eye care professionals and clinics. One of its key products, MatchedFlicker, is designed to monitor the onset and progression of glaucoma by detecting changes in time series retinal photographs. The technology automates the alignment and registration of images taken at different times, generating a superimposed view that facilitates analysis. Additionally, EyeIC's platform includes built-in interpretation and reporting tools, streamlining documentation and claims submission while assisting clinicians in identifying various retinal conditions, including diabetic retinopathy and retinopathy of prematurity. Through its advancements, EyeIC aims to enhance clinical workflows and improve patient care in the field of ophthalmology.

CD Diagnostics

Seed Round in 2012
CD Diagnostics is developing assays for orthopaedic surgeons and rheumatologists who would like greater diagnostic confidence in joint fluid analysis. Unlike current technologies, which often yield vague and ambiguous results, CygnaSure™, our lead product, offers orthopaedic surgeons and rheumatologists a rapid, accurate and reliable diagnostic answer.

Real Time Tomography

Seed Round in 2011
Real Time Tomography, LLC is a company focused on developing innovative imaging software solutions for medical imaging systems, particularly in the field of breast cancer detection. Founded in 2006 and based in Villanova, Pennsylvania, the company offers products such as Adara, which enhances digital mammography images to improve tissue contrast and lesion visibility, and Briona, a 3D image reconstruction software that transforms 2D projection images into detailed 3D tomographic images. Real Time Tomography also provides technical support and consultation for optimizing detector and system design to enhance image quality and processing speed. Their solutions are primarily aimed at manufacturers of mammography systems and PACS workstations, contributing to advancements in diagnostic accuracy and clinical workflow efficiency in the healthcare sector.

Essential Medical

Seed Round in 2011
Essential Medical, Inc. is a medical device company based in Malvern, Pennsylvania, that specializes in the development and marketing of femoral artery vascular closure devices. Founded in 2010, the company focuses on sealing femoral punctures that occur after diagnostic and interventional cardiac catheterization procedures. Essential Medical has developed two key devices, including MANTA, which is designed to close large bore punctures ranging from 10 to 24 French following various vascular access procedures such as transcatheter aortic valve replacement, abdominal aortic aneurysm repair, and balloon aortic valvuloplasty. These closures are critical in the rapidly growing field of interventional cardiology, enabling physicians to address the need for efficient and complication-free closure solutions. As of October 2018, Essential Medical operates as a subsidiary of Teleflex Incorporated.

Essential Medical

Seed Round in 2010
Essential Medical, Inc. is a medical device company based in Malvern, Pennsylvania, that specializes in the development and marketing of femoral artery vascular closure devices. Founded in 2010, the company focuses on sealing femoral punctures that occur after diagnostic and interventional cardiac catheterization procedures. Essential Medical has developed two key devices, including MANTA, which is designed to close large bore punctures ranging from 10 to 24 French following various vascular access procedures such as transcatheter aortic valve replacement, abdominal aortic aneurysm repair, and balloon aortic valvuloplasty. These closures are critical in the rapidly growing field of interventional cardiology, enabling physicians to address the need for efficient and complication-free closure solutions. As of October 2018, Essential Medical operates as a subsidiary of Teleflex Incorporated.

Bionano Genomics

Seed Round in 2006
Bionano Genomics, Inc. is a biotechnology company focused on genome mapping and analysis. It develops and markets the Saphyr system, an advanced platform designed for ultra-sensitive and specific detection of structural variations in DNA, such as insertions, deletions, and translocations, which are often linked to genetic disorders and diseases, including cancer. The Saphyr system employs optical genome mapping technology, allowing for direct visualization and analysis of long DNA molecules without relying on sequencing. This capability provides researchers and clinicians with critical insights into the structural variations within genomes, enhancing the understanding of disease mechanisms and supporting the development of personalized treatment strategies. Bionano Genomics also offers essential reagents and data solutions, including Bionano prep kits, labeling kits, and software tools for comprehensive experiment management. Its products are primarily sold to academic and governmental research laboratories, as well as pharmaceutical, biotechnology, and contract research organizations across multiple regions, including North America, Europe, and Asia. Founded in 2003 and headquartered in San Diego, California, the company was previously known as BioNano Genomics, Inc. until its name change in July 2018.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.